If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Henry is the inaugural director of the Centre for the Health Economy at Macquarie University (MUCHE), currently leading a team of 12 health economics researchers.

He is an applied health economist with extensive skills in evaluating real world problems, having undertaken a consulting role to government and non-government organisations for 15 years.

His work uses a variety of quantitative techniques, including economic evaluation, data analytics, choice modelling, panel data econometrics, Markov modelling, decision tree analysis, geospatial mapping, and survey design and implementation.

Henry has led close to 80 health economics consultancy projects over the last decade, with funding associated with these projects totalling approximately $8.5 million.

He has also gained research experience across a broad health care base. This includes cancer, visual impairment, dementia, cardiovascular disease, diabetes, chronic kidney disease, road trauma, sleep disorders, mental health, hearing, pathology, pharmaceuticals, medical devices, aged care, integrated care, digital health and hospitals.

He has contributed significantly to media over the last five years, including Australian Financial Review, The Australian, ABC News, ABC Radio National, ABC’s Lateline, ABC’s The Business, BRW, In the Black, Medical Observer, Australian Doctor, Aged Care Insight, Australian Ageing Agenda, and Hospital and Ageing.

Prior to joining MUCHE, Henry led the health economics team at KPMG, and was head of the Sydney Health Economics and Social Policy team for Access Economics. He also worked as a senior economic consultant the Centre for International Economics for five years, and spent eight years in the debt, equity and derivative markets, both in Australia and the UK.

Research interests

Health Economics

Quantitative Analysis

Health and Aged Care policy evaluation

Economic evaluation

Research engagement

Australian Health Economics Association

International Health Economics Association

International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Centre for Implementation of Hearing Research (iHEAR)

NHMRC Centre for Research Excellence in Digital Health

Digital Health Cooperative Research Centre

 

Education/Academic qualification

Economics, PhD, UNSW Australia

Master of Economics, University of Sydney

Economics, Bachelor of Business, University of Technology Sydney

External positions

Committee Member, LifeSpan Research and Advisory Committee, Black Dog Institute

Committee Member, Innovation Education and Training (RITE) Committee, Northern Sydney Local Health District

Expert Advisory Panel Member - Osteoporosis, The Sax Institute

Expert Advisory Panel Member - Cardiovascular Disease , The Sax Institute

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Cost-Benefit Analysis Medicine & Life Sciences
Costs and Cost Analysis Medicine & Life Sciences
Economics Medicine & Life Sciences
Tryptamines Medicine & Life Sciences
Dementia Medicine & Life Sciences
Vision Disorders Medicine & Life Sciences
Quality-Adjusted Life Years Medicine & Life Sciences
Migraine Disorders Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2022

Research Output 2008 2019

  • 58 Citations
  • 1 h-Index
  • 28 Commissioned report
  • 4 Meeting abstract
  • 2 Article

Cost-effectiveness of reclassifying triptans in Australia: Application of an economic evaluation approach to regulatory decisions

Parkinson, B., Gumbie, M., Cutler, H., Gauld, N., Mumford, V. & Haywood, P., Mar 2019, In : Value in Health. 22, 3, p. 293-302 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Tryptamines
Cost-Benefit Analysis
Migraine Disorders
Pharmacists
Headache Disorders

Cost-effectiveness of down scheduling triptans in Australia

Parkinson, B., Gumbie, M. & Cutler, H., 2018, In : Value in Health. 21, Suppl. 2, p. S94 1 p., PND16.

Research output: Contribution to journalMeeting abstractResearch

Tryptamines
Cost-Benefit Analysis
Migraine Disorders
Headache Disorders
Costs and Cost Analysis
Decision Support Techniques
Hearing Loss
Cost-Benefit Analysis
Quality-Adjusted Life Years
Costs and Cost Analysis

Is the oral contraceptive pill Rx to OTC switch cost-effective?

Gumbie, M., Parkinson, B. & Cutler, H., 2018, In : Value in Health. 21, Suppl. 2, p. S59 1 p., PIH9.

Research output: Contribution to journalMeeting abstractResearch

Oral Contraceptives
Costs and Cost Analysis
Contraceptive Agents
Quality-Adjusted Life Years
Pregnancy Outcome

Assessing choice for public hospital patients

Cutler, H., Gu, Y. & Olin, E., May 2017, Macquarie University, Centre for the Health Economy. 74 p.

Research output: Book/ReportCommissioned reportResearchpeer-review

Open Access

Prizes

Deans Research Excellence Award (Funding)

Henry Cutler (Recipient), 2017

Prize: Other distinction

Activities 2011 2018

Will public hospital patients choose a better quality hospital given the choice?

Henry Cutler (Speaker)
Jun 2018

Activity: Talk or presentationOral presentation

Is reclassifying the oral contraceptive pill to over-the-counter cost-effective?

Henry Cutler (Speaker)
2018

Activity: Talk or presentationOral presentation

Is reclassifying the oral contraceptive pill to over-the-counter cost-effective?

Henry Cutler (Speaker)
Jul 2018

Activity: Talk or presentationInvited talk

Will public hospital patients choose a better quality hospital given the choice?

Henry Cutler (Speaker)
Apr 2017

Activity: Talk or presentationInvited talk

The use and usefulness of outcomes based funding models for hospitals’

Henry Cutler (Speaker)
Sep 2017

Activity: Talk or presentationOral presentation

Press / Media

Poor diagnosis for budget’s health spending

Henry Cutler

10/05/18

1 media contribution

Press/Media: Other

Why the $6 billion subsidy to the private health insurance industry isn't working

Henry Cutler

18/04/18

1 media contribution

Press/Media: Public Engagement Activities

Muted market response to private health insurance reforms

Henry Cutler

13/10/17

1 media contribution

Press/Media: Other

Health cover reforms get mixed diagnosis

Henry Cutler

13/10/17

1 media contribution

Press/Media: Other